Arcutis Biotherapeutics Inc. (ARQT)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
5 |
$47,560 |
| Sells |
33 |
$4,463,395 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 03 Dec 2024 |
EDWARDS LARRY TODD |
See Remarks |
30 Nov 2024 |
1,093 |
7.11 |
7,767 |
| 03 Dec 2024 |
MATSUDA MASARU |
See Remarks |
30 Nov 2024 |
1,657 |
7.11 |
11,775 |
| 03 Dec 2024 |
MATSUDA MASARU |
See Remarks |
31 May 2024 |
4,000 |
1.69 |
6,768 |
| 03 Dec 2024 |
WATANABE TODD FRANKLIN |
See Remarks |
30 Nov 2024 |
2,038 |
7.11 |
14,482 |
| 06 Mar 2024 |
HERON PATRICK J |
Director |
04 Mar 2024 |
21,052 |
9.50 |
199,994 |
| 01 Dec 2023 |
WATANABE TODD FRANKLIN |
See Remarks |
31 May 2023 |
1,463 |
6.38 |
9,334 |
| 26 Oct 2023 |
FRAZIER LIFE SCIENCES VIII, L.P. |
10% |
24 Oct 2023 |
80,000 |
2.50 |
200,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock